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Rhodococcus equi is a well-known pathogen in veterinary 
medicine. It is also a rare but emerging opportunistic 
pathogen in immunocompromised patients. Since the 
first description ofa human infection in 1967 [l], about 
50 cases have been reported. The incidence of human 
R. equi infection is increasing, largely owing to the 
human immunodeficiency virus (HIV) pandemic [2-51. 
We present a case of R. equi bacteremia in an HIV-1- 
infected child, in whom the opportunistic infection 
revealed HIV-1 infection. 
A 5-year-old girl was referred to St Mary Pediatric 
Hospital in Iasi, Romania, with fatigue, loss of appetite, 
weight loss, dry cough and fever (38-4OOC) in August 
1994. The fever had started 3 weeks previously and 
persisted despite ambulatory treatment with penicillin 
and ampicillin. 
O n  examination she had micropolyadenopathy 
with painless, mobile, asymmetric nodes, tonsillar 
hypertrophy and hepatomegaly. Fine crackles were 
heard on both sides of her chest. She had tachycardia 
(120 beatslmin) and a systolic murmur in all the 
auscultation points. The peripheral white blood cell 
count was 11.4x109/L, with 74% neutrophils. No 
evidence of pneumonia was observed on the chest 
radiograph. 
A Gram-positive coccobacillus was isolated from 
two of three blood samples, after 4 and 7 days in 
culture. The colonies were small, irregular, round, 
smooth, :semi-transparent, mucoid and salmon-pink. 
The bacterium was pleomorphic, ranging from 
distinctly coccoid to rod-shaped. It was an obligate 
aerobe, catalase positive, oxidase negative and urease 
positive. R. equi infection was confirmed by full 
identification at the Pasteur Institute in Paris @r  M. 
Kiredjian). 
The disk diffusion method showed that the two 
isolates were sensitive to penicillin, ampicillin, ceftria- 
xone (MIC 0.03 mg/L), cehzidime (MIC 0.05 mg/L), 
cefotaxime (MIC 0.03 mg/L), erythromycin, genta- 
micin and co-trimoxazole, intermediately susceptible 
to rifampicin, and resistant to tetracycline. 
SpeciFic parented therapy was started with ceftria- 
xone, and gentamicin was added 4 days later. A clinical 
and biological response was observed after 24 h, fever 
started to abate on day 2 and ceased on day 5, and the 
C reactive protein level was normal by day 7. This 
treatment 'was maintained for 2 weeks and was followed 
by ampicillin therapy for 35 days. As R. equi infection 
occurs mainly in immunocompromised hosts, the 
patient was tested for HIV-1 infection; serotyping by 
subtype-specific enzyme immunoassay (SSEIA) showed 
she was infected by HIV-1 subtype F [6]. Flow cyto- 
metry showed a CD4/CD8 cell ratio of 0.65 (CD4 cell 
count: 380 x 106/L). She made a full recovery and did 
not relapse on treatment withdrawal. 
This case has several interesting features: 
(1) To our knowledge this is the first description of 
R. equ,i infection in an HIV-I-infected child. She 
had had no known contact with animals and no 
specific site of infection; in particular, there was 
no clinical or radiologic evidence of pulmonary 
involvement, in contrast to the majority of reported 
cases [I-3,5,7]. 
(2) R. equi infection was diagnosed prior to the 
discovery of HIV-1 infection, and was the first 
clinical manifestation of HIV- 1 disease. 
(3) The response to antibiotic therapy was favorable, 
after a short course (2 weeks) of cehiaxone and 
gentamicin, followed by 35 days of ampicillin. This 
confirms a previous report showing the efficacy of 
ceftriaxone in the treatment ofR. equi infection [7]. 
In contrast, there have been several reports of 
treatment failure in immunocompromised patients 
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despite prolonged therapy with drugs shown to 
be active in vitro [8]. We observed no recurrence 
of clinical symptoms on the discontinuation of 
therapy with cefiriaxone and gentamicin. 
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Symptomatic occupational transmission of hepatitis C 
virus (HCV) 
Clin Microbial Infect 1998; 4: 354 
Previous reports suggest that there is a low risk of 
occupational transmission of hepatitis C virus (HCV) 
among healthcare workers [l], but it has been shown 
to occur [ 2 ] .  We present our experience of following 
up needlestick accidents involving biological fluids 
from patients who were HCV-antibody positive. Since 
1990, 87 such episodes have been reported to the 
Preventive Medicine Unit of this hospital. These 
involved 14 physicians (16%), 46 nurses (53%) and 27 
ancillary personnel (31%). Thirty-nine of these patients 
were also HIV-antibody positive, and a further one was 
both anti-HIV and HBsAg positive. Antibodies to HIV 
and HCV and HBsAg were detected with commercial 
tests (years 1990-93, Abbott; years 1994-96, Boehringer 
Mannheim). 
Serum samples were taken from each staff member 
at 0 (loo%), 3 (loo%), 6 (94%) and 12 (77%) months 
after the episode. Two were already anti-HCV positive 
at the time of the accident. One nurse, involved in an 
accident with a patient positive only for anti-HCV, 
developed acute clinical hepatitis (ALT 2750 IU) 6 
weeks later, with seroconversion by ELISA and Western 
blot (corefNS3, Murex Diagnostics). HCV KNA was 
also detected in both patient and nurse. The accident 
consisted of a double needlestick injury to the fourth 
finger of the right hand. The nurse was enrolled in an 
acute HCV interferon treatment protocol at a reference 
hospital and the infection was cleared. There was no 
seroconversion to either HBV or HIV in any of the staff 
members involved. 
Our  study confirms a low rate of occupational 
transmission of HCV (1.15%, 95% CI: 0.06-7.13%) 
but we report another documented symptomatic case 
and, in the absence of specific preventative measures, 
we reiterate the need for universal precautions. 
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